Yearly Archives: "2021"

Coronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for AstraZeneca’s Evusheld (tixagevimab [...]
Coronavirus (COVID-19) update: FDA authorizes new long-acting monoclonal antibodies
Coronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain [...]
Elucidating the Association of Epstein-Barr Virus and Multiple Sclerosis
Scott Newsome, DO, leads a panel discussion with thought leaders on the implications of findings from a recently published longitudinal [...]
More About MS (2021)
In this program, people living with or affected by MS will have the opportunity to network with one another and to learn from leading MS [...]
Ublituximab, potential relapsing multiple sclerosis therapy, up for FDA approval
TG Therapeutics has applied to the U.S. Food and Drug Administration (FDA) for approval of ublituximab, the company’s investigational [...]
NeurologyLive® announces the inaugural Giants of Multiple Sclerosis™ Program
NeurologyLive® Announces the Inaugural Giants of Multiple Sclerosis™ Program The first annual award program will honor [...]
The Brain Under Siege by Dr. Howard Weiner
The CMSC and IOMSN are proud to announce the following: Dr. Howard L. Weiner has just written a new book on brain diseases called The [...]
Introducing Atara Biotherapeutics: the role of EBV in multiple sclerosis and the Phase II EMBOLD study
Consortium of Multiple Sclerosis Centers (CMSC) and Atara Biotherapeutics on Thursday - June 10, 2021 at 7:00 PM - 8:00 PM ET on an [...]
MRI in Multiple Sclerosis Guidelines Update: North America, Europe align on new recommendations
These consensus guidelines are significant not only for their key updates to clinical practice but for their representation of a more [...]
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
Prof Mike P Wattjes, MD, Prof Olga Ciccarelli, MD, Daniel S Reich, MD, Prof Brenda Banwell, MD, Prof Nicola de Stefano, MD, Prof Christian [...]

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us





I have a question about

First

Last




Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM